Replimune Group, Inc. Class Action Lawsuit
Company: Replimune Group, Inc.
Ticker: (NASDAQ) REPL
Class Action Period: October 20, 2025 - April 10, 2026
See If You Qualify For Monetary Reward
Join the Replimune Group, Inc. Class Action Lawsuit
CLASS ACTION PERIOD
October 20, 2025 - April 10, 2026
Allegations
The complaint filed against Replimune Group, Inc. alleges the company made statements that were materially false and/or misleading and/or failed to disclose that: (1) in connection with the BLA, the study design concerns previously communicated by the FDA were not addressed; (2) the Company had submitted data from an early unplanned analysis from RP1-104, which included only 40 patients (10% of the planned enrollment of 400 patients); (3) as a result, RPL-001-16 and RP1-104 both had deficiencies which were likely to cause the FDA to reject the BLA; and (4) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Eligibility
To be eligible for the lawsuit, you must have experienced a loss on Replimune Group, Inc. shares purchased within the class period specified above.
Lead Plaintiff Deadline
If you suffered a loss in Replimune Group, Inc. during the relevant time frame or pursuant to the relevant offering(s), you have until October 5, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Frequently Asked Questions
- How can Replimune Group, Inc. (NASDAQ: REPL) investors check whether their transactions may be relevant?
Investors who purchased shares of Replimune Group, Inc. (NASDAQ: REPL) during the class period (October 20, 2025 - April 10, 2026) may submit their transaction details through this case page.
- Ensure your purchase falls within the class period
- Provide basic transaction and loss details
- Submit your information before the deadline
The lead plaintiff deadline for this case is October 5, 2026. This deadline applies only to investors seeking to serve as lead plaintiff. Class members who do not apply may still participate in any recovery without taking action before this date.
- Who is eligible for the Replimune Group, Inc. lawsuit?
Anyone who bought shares of Replimune Group, Inc. (NASDAQ: REPL) during October 20, 2025 - April 10, 2026 and suffered financial losses may be eligible.
- What is the lead plaintiff deadline to join the Replimune Group, Inc. case?
The lead plaintiff deadline for the Replimune Group, Inc. lawsuit is October 5, 2026. Investors who wish to seek appointment as lead plaintiff should act quickly to avoid missing this deadline. No action is required before that date to remain an absent class member.
- What is the class period for Replimune Group, Inc.?
The class period for Replimune Group, Inc. (NASDAQ: REPL) is October 20, 2025 - April 10, 2026, during which investors may have been affected by alleged misconduct.
- Could I still be eligible for the Replimune Group, Inc. lawsuit if I sold my shares?
Yes. Investors who purchased Replimune Group, Inc. shares during October 20, 2025 - April 10, 2026 may still qualify, even if they sold their shares later.
- How much compensation can I receive from the Replimune Group, Inc. lawsuit?
Compensation depends on the total losses and the final settlement. Eligible investors in the Replimune Group, Inc. case may receive a portion of the recovery.
- Do I need to pay to participate in the Replimune Group, Inc. case?
No. Most securities fraud cases are handled on a contingency basis, meaning there are generally no upfront attorney’s fees, and attorney’s fees are collected only if there is a recovery.
- Will I need to appear in court for the Replimune Group, Inc. lawsuit?
In most cases, investors do not need to appear in court. The legal team manages the Replimune Group, Inc. case on behalf of participants.
- What documents are required for the Replimune Group, Inc. lawsuit?
To participate in the Replimune Group, Inc. lawsuit, investors may need to provide transaction records, purchase dates, number of shares, and loss details.
- What happens after I submit my trade information for Replimune Group, Inc.?
After submission, your details for the Replimune Group, Inc. case will be reviewed, and you may be contacted regarding eligibility or next steps.
- Is this legal advice for the Replimune Group, Inc. lawsuit?
No, this page provides information about the Replimune Group, Inc. case and does not constitute legal advice or create an attorney-client relationship.
- Why should I act quickly on the Replimune Group, Inc. case?
The lead plaintiff deadline for the Replimune Group, Inc. lawsuit is October 5, 2026. Investors who wish to seek appointment as lead plaintiff must apply by that date.
EXPLORE MORE CASES
Embecta Corp.
EMBC
Embecta Corp. (EMBC) Securities Class Action Lawsuit Update
Lead Plaintiff Deadline: August 17, 2026
Class Period: November 25, 2025 - May 4, 2026
First Solar, Inc.
FSLR
First Solar, Inc. (FSLR) Securities Class Action Lawsuit Update
Lead Plaintiff Deadline: August 24, 2026
Class Period: February 26, 2025 - February 24, 2026